Update shared on 25 Nov 2025
Fair value Increased 2.26%Analysts have raised their price target for China Literature from $39.17 to $40.06, citing minor improvements in projected revenue growth and future valuation metrics.
What's in the News
- Between January 1, 2025 and May 30, 2025, China Literature repurchased 6,138,800 shares, amounting to 0.6% of its total shares, for HKD 152.84 million. (Key Developments)
- This brings the total shares repurchased under the buyback announced on June 21, 2024 to 13,865,800 shares, representing 1.36% of shares, for a total consideration of HKD 422.78 million. (Key Developments)
- In a new tranche from June 2, 2025 to June 30, 2025, the company repurchased an additional 200,000 shares, or 0.02% of shares, for HKD 5.18 million. (Key Developments)
Valuation Changes
- The consensus analyst price target has risen slightly, up from HK$39.17 to HK$40.06 per share.
- The discount rate remains unchanged at 7.02%.
- Revenue growth projections have increased marginally, from 8.31% to 8.37%.
- Net profit margin estimates have fallen slightly, from 19.09% to 19.06%.
- The future P/E ratio has edged up, moving from 25.19x to 25.62x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.